Protara Therapeutics, Inc. (TARA)

3.88 +0.03 (+0.78%) USD  |  NASDAQ  |  Aug 24, 16:00
3.88 0.00 (0.00%) After-Hours: 20:00
More

Protara Therapeutics EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for TARA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical EPS Diluted (5 Year Growth) Data

View and export this data back to 2017. Start Trial.
Date Value
December 31, 2025 --
December 31, 2024 --
December 31, 2023 --
December 31, 2022 --
December 31, 2021 --
Date Value
December 31, 2020 --
December 31, 2019 --
December 31, 2018 --
December 31, 2017 --

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
NovelStem International Corp. Upgrade
Brainstorm Cell Therapeutics, Inc. Upgrade
Summit Therapeutics, Inc. Upgrade
Kezar Life Sciences, Inc. Upgrade
Clene, Inc. Upgrade